Skip to content

Analysis of the therapeutic effect of endoscopic high suspension of hemorrhoidal mucosa followed by serial ligation for the treatment of grade II-III internal hemorrhoids

Analysis of the therapeutic effect of endoscopic high suspension of hemorrhoidal mucosa followed by serial ligation for the treatment of grade II-III internal hemorrhoids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096878
Enrollment
Unknown
Registered
2025-02-08
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

II-III degree internal hemorrhoids

Interventions

Simple ligation group:Simple ligation
Suspension series tie group:Suspension series tie

Sponsors

Henan Provincial People's Hospita,medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of Grade II-III internal hemorrhoids with symptoms of bleeding and/or prolapse; 2.The patient has a willingness to receive treatment; 3. Age over 18 years old; 4. Sign the informed consent form for treatment.

Exclusion criteria

Exclusion criteria: 1.Recently developed thrombosed external hemorrhoids; 2.Accompanied by perianal infectious diseases, anal fistula or in the active stage of inflammatory bowel disease; 3.Has undergone endoscopic treatment (such as sclerotherapy, ligation, etc.) or surgical treatment (such as hemorrhoidectomy) within the past 6 months; 4. Coagulation function and platelet abnormalities cannot be treated with ligation; 5. Continuous anticoagulant therapy (using warfarin or heparin) or high-dose aspirin and/or nonsteroidal anti-inflammatory drugs are required for thrombotic diseases; 6. Serious or end-stage diseases, including cirrhosis, portal hypertension, severe renal or respiratory failure, sepsis, active rectal infection, and acquired immune deficiency syndrome;

Design outcomes

Primary

MeasureTime frame
Effective rate and recurrence rate of internal hemorrhoid treatment;

Secondary

MeasureTime frame
The occurrence of postoperative adverse events (pain, bleeding, etc.);Surgical satisfaction;

Countries

China

Contacts

Public ContactDing hui

Henan Provincial People's Hospita,medical

dinghui76sy@163.com+86 371 65897750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026